Sustained effect of macitentan, a novel oral endothelin receptor antagonist, on exercise capacity and the association of its measure with long-term outcomes in pulmonary arterial hypertension
Galie, N., Channick, R., Delcroix, M., Ghofrani, H.- A., Jansa, P., Le Brun, F.- O., Simonneau, G., Rubin, L. J.Volume:
34
Language:
english
Journal:
European Heart Journal
DOI:
10.1093/eurheartj/eht308.1061
Date:
August, 2013
File:
PDF, 52 KB
english, 2013